F1 Pharma receives further financial support for new R&D project from regional funds
Recently we received information on the positive recommendation of the Małopolska Centre for Entrepreneurship regarding our application for the subsidization of our new R&D project entitled “The development of innovative forms of oral drugs dedicated for children and elderly persons suffering from dysphagia”.
The project is co-funded by the European Union from the European Regional Development Fund, in the course of the Regional Operational Programme for the Małopolska Region, Priority Axis 1 - Knowledge Economy, Measure 1.2 Research and Innovation in Enterprises, Sub-Measure 1.2.1 Research & Projects in Enterprises.
The aim of this project is to carry out R&D works leading to the development of innovative formulations of specific, generic drugs, in order to meet the needs of patients suffering from dysphagia, including children and the elderly. The project will entail works leading to the development of the drug formula and manufacturing technology for the new medicinal products followed by the development and validation of analytical methods used for the control of product critical quality parameters. Pilot scale batches of each product, manufactured in GMP conditions, will be subjected to stability tests in order to confirm the maintenance of product quality during estimated shelflife. The complete documentation needed for the registration procedure will be provided.
Value of project: 3 710 138.28 PLN
EU Funding: 2 731 995.92 PLN